SAN DIEGO, May 26, 2020/ PRNewswire/– Medical Cannabis, Inc.( OTC: MJNA) (the “Business”), the first-ever openly traded marijuana business in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brand names and supply chain, revealed today that it has welcomed Earl Monroe, previous NBA player for the Baltimore Bullets and the New York City Knicks, to its subsidiary Kannaway ®‘s Sports Group to help spread out awareness on the benefits of cannabidiol (CBD) for professional athletes, previous professional athletes and those who are just aiming to lead a healthy, active way of life.
” What an honor that Earl Monroe is using our Premium Full Spectrum CBD and topical salve products. A real legend in his own right, we might not be more happy and are really happy that our items have actually made a positive difference for Earl,” stated Kannaway ® CEO Blake Schroeder. “Our Kannaway Sports Group helps us notify consumers and make them feel more positive to include CBD into their every day lives.”
In addition, Monroe has actually gotten many community honors including the Most Outstanding Model for American Youth Award, Harlem Professionals Inspirational Award, YMCA Citizenship Award and Huge Apple Sportsman of the Year Award.
Kannaway ® was the very first direct sales company to offer phyto-cannabinoid botanical products to customers. A family oriented company, Kannaway ® motivates its brand name ambassadors to create their own successful circulation businesses that will favorably benefit to the wellness of individuals around them. Recently, Kannaway ® was the winner of a Gold Stevie ® Award in the Medium Business of the Year – Health Products & Solutions classification in The 17 th Yearly American Service Awards ®.
” I’ve been using Kannaway’s products for about a year now and I can observe that I feel in general less throbbing and much better than before I began taking CBD items,” said Monroe.
About Kannaway ®
Kannaway ® is a network sales and marketing company concentrating on the sales and marketing of hemp-based botanical products. Kannaway ® presently hosts weekly online sales conferences and conferences across the United States, offering unique insight and chance to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical items.
About Medical Cannabis, Inc.
We are a business of firsts ® Medical Marijuana, Inc.( MJNA) is a cannabis company with three distinct company systems in the non-psychoactive cannabinoid space: an international portfolio of cannabinoid-based nutraceutical brand names led by Kannaway ® and HempMeds ® ; a leader in sourcing the highest-quality legal non-psychoactive marijuana items stemmed from commercial hemp; and a cannabinoid-based medical research study and botanical drug advancement sector led by its pharmaceutical investment companies and partners consisting of AXIM ® Biotechnologies, Inc and Kannalife, Inc Medical Marijuana, Inc. was named a leading CBD manufacturer by CNBC Medical Marijuana, Inc. was likewise the very first company to get historical import permits for CBD items from the federal governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the advancement of global markets. The business’s flagship product Genuine Scientific Hemp Oil has been utilized in numerous successful scientific research studies throughout Mexico and Brazil to comprehend its safety and efficacy.
Medical Cannabis, Inc.’s headquarters is in San Diego, California, and extra details is offered at OTCMarkets.com or by checking out www.medicalmarijuanainc.com To see Medical Marijuana, Inc.’s corporate video, click on this link
Shareholders and consumers are also motivated to purchase CBD oil and other items at Medical Cannabis, Inc.’s shop.
This press release may consist of particular positive declarations and info, as defined within the meaning of Area 27 A of the Securities Act of 1933 and Area 21 E of the Securities Exchange Act of 1934, and goes through the Safe Harbor created by those areas. This material includes declarations about predicted future occasions and/or financial results that are forward-looking in nature and subject to threats and unpredictabilities. Such forward-looking declarations by meaning involve threats, uncertainties and other aspects, which might cause the actual outcomes, performance or achievements of Medical Cannabis, Inc. to be materially various from the statements made herein.
FDA (FDA) DISCLOSURE
These declarations have actually not been examined by the Fda. This item is not planned to detect, deal with, treat, or avoid any illness.
Medical Cannabis, Inc. does not sell or disperse any items that are in offense of the United States Controlled Substances Act.
Investor Relations Contact:
P. (858) 283-4016
SOURCE Medical Cannabis, Inc.